Evidence map›Paper›PMID 39942810›Full record

ReviewMolecules (Basel, Switzerland)2025

Innovative Syntheses and Reactivity of Propiolamidines.

Carlos Ginés, Blanca Parra-Cadenas, Fernando Carrillo-Hermosilla, David Elorriaga

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carlos GinésDepartamento de Química Inorgánica, Orgánica y Bioquímica-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Facultad de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.
Blanca Parra-CadenasDepartamento de Química Inorgánica, Orgánica y Bioquímica-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Facultad de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.ORCID 0000-0002-2528-3778
Fernando Carrillo-HermosillaDepartamento de Química Inorgánica, Orgánica y Bioquímica-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Facultad de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.ORCID 0000-0002-1187-7719
David ElorriagaDepartamento de Química Orgánica, Inorgánica y Bioquímica-INAMOL, Facultad de Ciencias Ambientales y Bioquímica, Universidad de Castilla-La Mancha, 45071 Toledo, Spain.ORCID 0000-0002-7063-379X

Funding

JCCM and EU through INNOCAM and Fondo Europeo de Desarrollo Regional, FEDER SBPLY/23/180225/000021MICIU/AEI /10.13039/501100011033 PID2020-117353GB-I00 and RED2022-134287-TUniversidad de Castilla-La Mancha 2022-GRIN-34031
6 · The paper itself

Abstract

Polydentate ligands with nitrogen donor atoms have possibly given rise to the largest group of coordination complexes described. Among these ligands, amidinates represent a nitrogenated version of carboxylates and allow the formation of complexes with most elements in the periodic table, adopting chelate or bridge coordination modes. The precursors of these ligands, amidines, can present an alkynyl group as the substituent of their central atom, R'N=C(C≡CR)NHR', which provides an additional point of reactivity for these molecules, as well as a different electronic behavior compared to conventional amidines with alkyl groups on the central carbon atom of the amidine group. These propiolamidines have been obtained through classical stoichiometric organic synthesis procedures or, with greater atomic economy, through catalytic procedures based on Main Group, Transition, or Rare Earth metals. This work reviews these synthesis methods, as well as the reactivity in the obtention of new, more complex heterocyclic organic molecules.

Indexed as

amidinecatalysisheterocyclepropiolamidine

Identifiers

PMID39942810
PMCPMC11819876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.